©The Author(s) 2020.
World J Hepatol. May 27, 2020; 12(5): 207-219
Published online May 27, 2020. doi: 10.4254/wjh.v12.i5.207
Published online May 27, 2020. doi: 10.4254/wjh.v12.i5.207
Table 3 Histopathological patterns, R ratios and Drugs/HDS in our study
| Histopathological pattern | R ratio | Total, n = 38 (%) | Drugs/HDS (n) |
| Hepatitis | 12 ± 0.4 | 18 (47.4) | |
| Acute | 16 ± 0.1 | 5 (13.2) | Nitrofurantoin (1) |
| Black cohosh1 (1) | |||
| Sertraline (1) | |||
| Lamotrigine (1) | |||
| Green tea extract (1) | |||
| Acute with extensive necrosis | 11 ± 3.3 | 8 (21.1) | Diclofenac (1) |
| Acetaminophen (6) | |||
| Black cohosh1 (1) | |||
| Autoimmune-like | 6.2 ± 0.1 | 3 (7.9) | Infliximab (2) |
| Isoniazid (1) | |||
| Chronic | 8.8 | 1 (2.6) | Nitrofurantoin (1) |
| Non-necrotizing granulomatous hepatitis | 14 | 1 (2.6) | BCG (1) |
| Cholestasis | 0.5 ± 0.1 | 5 (13.2) | |
| Acute | 0.4 ± 0.5 | 4 (10.5) | Ceftriaxone (1) |
| Methimazole (1) | |||
| Total parenteral nutrition (1) | |||
| Rivaroxaban (1) | |||
| Chronic | 0.8 | 1 (2.6) | Triazolam and statin (1) |
| Cholestatic hepatitis | 9.0 ± 5.6 | 8 (21.1) | Ezetimibe (1) |
| Cefazolin (1) | |||
| Hydroxycut2 (1) | |||
| Rizatriptan5 (1) | |||
| Methyldrostanolone (1) | |||
| Trimethobenzamide Hydrochloride5 (1) | |||
| Mesalamine (1) | |||
| C4 extreme3 (1) | |||
| Macrovesicular steatohepatitis | 1.4 ± 1.2 | 5 (13.2) | Trimethoprim-sulfamethoxazole6 (1) |
| L-asparaginase (1) | |||
| Valproic acid (1) | |||
| Haart4 (1) | |||
| Amiodarone (1) | |||
| Mixed cholestatic hepatitis with steatosis and bile duct injury | 1.1 ± 0.8 | 2 (5.3) | Dronedarone6 (1) |
| Hydroxycut26 (1) |
- Citation: Siddique AS, Siddique O, Einstein M, Urtasun-Sotil E, Ligato S. Drug and herbal/dietary supplements-induced liver injury: A tertiary care center experience. World J Hepatol 2020; 12(5): 207-219
- URL: https://www.wjgnet.com/1948-5182/full/v12/i5/207.htm
- DOI: https://dx.doi.org/10.4254/wjh.v12.i5.207